Physician Assistant · Houston, TX
NPI
1144765256
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,842
170 services
Medicare patients, 2024
117
Average age 73
Drug cost, 2024
$3.3M
729 prescriptions
Company payments, 2025
$23K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samantha Salvatora was code 99213 (office e&m - established), 64 times for 51 patients. In total Samantha Salvatora billed 170 services in 10 codes, and Medicare paid $5,842.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 64 | 51 | $42.15 | $2,698 |
| 99212 Office E&M - Established | Facility | 51 | 42 | $21.60 | $1,102 |
| 99441 Telephone Services | Facility | 26 | 21 | $22.41 | $583 |
By year: 2022 $7,983 for 203 services; 2023 $7,008 for 208 services; 2024 $5,842 for 170 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samantha Salvatora prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 112 prescriptions and refills. In total Samantha Salvatora wrote 729 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 112 | 158 | 29 | $2,837 |
| Allopurinol Generic | 81 | 135 | 26 | $529 |
| Levofloxacin Generic | 62 | 66 | 22 | $1,547 |
| Bosulif Bosutinib | 41 | 41 | Under 11 | $550K |
| Sprycel Dasatinib | 34 | 34 | Under 11 | $285K |
| Posaconazole Generic | 32 | 32 | Under 11 | $46K |
| Potassium Chloride Generic | 30 | 33 | 11 | $850 |
| Jakafi Ruxolitinib Phosphate | 27 | 27 | Under 11 | $355K |
| Venclexta Venetoclax | 25 | 25 | Under 11 | $230K |
| Imbruvica Ibrutinib | 24 | 24 | Under 11 | $356K |
| Hydroxyurea Generic | 21 | 33 | Under 11 | $551 |
| Cefpodoxime Proxetil Generic | 18 | 18 | Under 11 | $3,431 |
| Inqovi Decitabine/Cedazuridine | 18 | 18 | Under 11 | $143K |
| Idhifa Enasidenib Mesylate | 16 | 16 | Under 11 | $519K |
| Ondansetron Odt Ondansetron | 14 | 14 | 11 | $182 |
Brand drugs: 217 claims; generic drugs: 512 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samantha Salvatora $23K ($23K in general payments such as food, travel and fees) from 15 companies. The largest payer was Syndax Pharmaceuticals, Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. SNDX | 29 | $19K |
| Incyte Corporation INCY | 12 | $2,078 |
| Astellas Pharma US Inc 4503.T | 8 | $364 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $358 |
| Abbvie Inc. ABBV | 4 | $354 |
| Celgene Corporation BMY | 8 | $203 |
| Lilly USA, LLC LLY | 3 | $162 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $97.66 |
| Geron Corporation GERN | 2 | $71.73 |
| GlaxoSmithKline, LLC. GSK | 3 | $67.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.